dc.contributor.author |
Millroy, L
|
|
dc.contributor.author |
London, G
|
|
dc.contributor.author |
Veale, R
|
|
dc.contributor.author |
Weinberg, M
|
|
dc.contributor.author |
Khati, M
|
|
dc.date.accessioned |
2011-09-22T08:20:40Z |
|
dc.date.available |
2011-09-22T08:20:40Z |
|
dc.date.issued |
2011-02 |
|
dc.identifier.citation |
Millroy, L, London, G, Veale, R et al. 2011. Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C. EMBO global exchange lecture course on HIV AIDS, Stellenbsoch, 30 January - 04 February 2011 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10204/5155
|
|
dc.description |
EMBO global exchange lecture course on HIV AIDS, Stellenbsoch, 30 January - 04 February 2011 |
en_US |
dc.description.abstract |
Aptamers are artificial nucleic acid ligands that can be engineered to bind with high specificity to a macromolecule. Their binding specificity and small size allow for a range of therapeutic applications. One avenue of research is to develop aptamers with specific and strong affinity to the HIV-1 envelope glycoprotein gp120 and act as novel HIV-1 entry inhibitor drugs or as targeted drug delivery systems to HIV-1 infected cells. Prior to any downstream applications, novel gp120 aptamers need to be biophysically characterised with regards to their target binding characteristics. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Conference Poster |
en_US |
dc.relation.ispartofseries |
Workflow request;5453 |
|
dc.subject |
Kinetics |
en_US |
dc.subject |
Binding kinetics |
en_US |
dc.subject |
Aptamers |
en_US |
dc.subject |
HIV AIDS |
en_US |
dc.subject |
HIV-1 |
en_US |
dc.title |
Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C |
en_US |
dc.type |
Conference Presentation |
en_US |
dc.identifier.apacitation |
Millroy, L., London, G., Veale, R., Weinberg, M., & Khati, M. (2011). Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C. Conference Poster. http://hdl.handle.net/10204/5155 |
en_ZA |
dc.identifier.chicagocitation |
Millroy, L, G London, R Veale, M Weinberg, and M Khati. "Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C." (2011): http://hdl.handle.net/10204/5155 |
en_ZA |
dc.identifier.vancouvercitation |
Millroy L, London G, Veale R, Weinberg M, Khati M, Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C; Conference Poster; 2011. http://hdl.handle.net/10204/5155 . |
en_ZA |
dc.identifier.ris |
TY - Conference Presentation
AU - Millroy, L
AU - London, G
AU - Veale, R
AU - Weinberg, M
AU - Khati, M
AB - Aptamers are artificial nucleic acid ligands that can be engineered to bind with high specificity to a macromolecule. Their binding specificity and small size allow for a range of therapeutic applications. One avenue of research is to develop aptamers with specific and strong affinity to the HIV-1 envelope glycoprotein gp120 and act as novel HIV-1 entry inhibitor drugs or as targeted drug delivery systems to HIV-1 infected cells. Prior to any downstream applications, novel gp120 aptamers need to be biophysically characterised with regards to their target binding characteristics.
DA - 2011-02
DB - ResearchSpace
DP - CSIR
KW - Kinetics
KW - Binding kinetics
KW - Aptamers
KW - HIV AIDS
KW - HIV-1
LK - https://researchspace.csir.co.za
PY - 2011
T1 - Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C
TI - Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C
UR - http://hdl.handle.net/10204/5155
ER -
|
en_ZA |